Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dimerix Bioscience Ltd updates on initial public offer


Monday, 7 Jul 2014 12:59am EDT 

Dimerix Bioscience Ltd:Says it is undertaking an initial public offer.Dimerix lodged a prospectus dated 12 June 2014 with the Australian Securities and Investments Commission (ASIC) in relation to the offer (Prospectus).Offer will only be made pursuant to the prospectus and full details of the offer are set out in prospectus.Closing date for offer and closing date for ASX bookbuild period has been extended to Aug. 1 unless closed earlier at the discretion of directors. 

Latest Developments for Dimerix Bioscience Ltd